Literature DB >> 6711681

The parathyroid adenoma. A histopathologic definition with a study of 172 cases of primary hyperparathyroidism.

L Ghandur-Mnaymneh, N Kimura.   

Abstract

There is unanimous agreement that parathyroid adenoma lacks precise histopathologic definition. Likewise, it is generally accepted that hyperplasia may involve the parathyroid glands unequally, causing tumorous enlargement of a single parathyroid gland. On the basis of observations of the histologic features of the normal parathyroid gland and on the accepted definition of an adenoma, and based on the concept of unequal or "focal" hyperplasia, histopathologic criteria for the recognition of adenoma and its differentiation from hyperplasia were formulated. Study of 172 cases of primary hyperparathyroidism with the use of these criteria showed that adenomas accounted for only 5.8% of cases of primary hyperparathyroidism and that hyperplasia with single gland enlargement accounted for 75.1%. The literature and data supporting the view that solitary masses of the parathyroid glands more often represent hyperplasia than adenoma are cited.

Entities:  

Mesh:

Year:  1984        PMID: 6711681      PMCID: PMC1900356     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Primary hyperparathyroidism. Clinical and structural findings in 138 cases.

Authors:  J HELLSTROM; B I IVEMARK
Journal:  Acta Chir Scand Suppl       Date:  1962

2.  Primary chief-cell hyperplasia of the parathyroid glands: a new entity in the surgery of hyperparathyroidism.

Authors:  O COPE; W M KEYNES; S I ROTH; B CASTLEMAN
Journal:  Ann Surg       Date:  1958-09       Impact factor: 12.969

3.  Tumors and hyperplasia of the parathyroid glands; a review of the pathological findings in 140 cases of primary hyperparathyroidism.

Authors:  L B WOOLNER; F R KEATING; B M BLACK
Journal:  Cancer       Date:  1952-11       Impact factor: 6.860

4.  The Pathology of the Parathyroid Gland in Hyperparathyroidism: A Study of 25 Cases.

Authors:  B Castleman; T B Mallory
Journal:  Am J Pathol       Date:  1935-01       Impact factor: 4.307

Review 5.  Reappraisal of parathyroid pathology in hyperparathyroidism.

Authors:  C B Esselstyn; H S Levin; J J Eversman; O P Schumacher; P G Skillern
Journal:  Surg Clin North Am       Date:  1974-04       Impact factor: 2.741

6.  Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands.

Authors:  E Reiss; J M Canterbury
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

7.  Peroperative fat staining of frozen sections in primary hyperparathyroidism.

Authors:  O Ljungberg; S Tibblin
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

8.  Parathyroid hyperplasia versus adenoma--clinical or histologic diagnosis.

Authors:  G A Sicard
Journal:  Surgery       Date:  1981-07       Impact factor: 3.982

9.  The rapid identification of "normal" parathyroid glands by the presence of intracellular fat.

Authors:  S I Roth; M J Gallagher
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

10.  The surgical treatment of primary hyperparathyroidism: a 20 year experience.

Authors:  R J Coffey; T C Lee; J J Canary
Journal:  Ann Surg       Date:  1977-05       Impact factor: 12.969

View more
  22 in total

1.  Single and multigland disease in primary hyperparathyroidism: clinical follow-up, histopathology, and flow cytometric DNA analysis.

Authors:  H J Bonjer; H A Bruining; J C Birkenhager; R H Nishiyama; M A Jones; C B Bagwell
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

2.  4D-Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism.

Authors:  J L Becker; V Patel; K J Johnson; M Guerrero; R R Klein; G F Ranvier; R P Owen; P Pawha; K Nael
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-12       Impact factor: 3.825

3.  Risk factors for treatment failure in surgery for primary hyperparathyroidism: the impact of change in surgical strategy and training procedures.

Authors:  Anders Rørbæk Madsen; Lars Rasmussen; Christian Godballe
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-05       Impact factor: 2.503

4.  MR appearance of parathyroid adenomas at 3 T in patients with primary hyperparathyroidism: what radiologists need to know for pre-operative localization.

Authors:  B Sacconi; R Argirò; Daniele Diacinti; A Iannarelli; M Bezzi; C Cipriani; D Pisani; V Cipolla; C De Felice; S Minisola; C Catalano
Journal:  Eur Radiol       Date:  2015-05-31       Impact factor: 5.315

5.  Can ARFI elastography be used to differentiate parathyroid from thyroid lesions?

Authors:  A Chandramohan; M Therese; D Abhraham; T V Paul; P Jacob Mazhuvanchary
Journal:  J Endocrinol Invest       Date:  2017-05-31       Impact factor: 4.256

6.  Histologic diagnosis of primary hyperparathyroidism: a concordance analysis between three pathologists.

Authors:  L Bornstein-Quevedo; A Gamboa-Domínguez; A Angeles-Angeles; E Reyes-Gutiérrez; F Vargas-Voráckova; R Gamino; M F Herrera
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

7.  Raman spectroscopy of parathyroid tissue pathology.

Authors:  Kaustuv Das; Nicholas Stone; Catherine Kendall; Clare Fowler; J Christie-Brown
Journal:  Lasers Med Sci       Date:  2006-09-22       Impact factor: 3.161

Review 8.  Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue.

Authors:  Tuvia Hadar; Jacob Shvero; Eitan Yaniv; Eduard Ram; Itzhak Shvili; Rumelia Koren
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

9.  The parathyroid gland in health and disease.

Authors:  L Ghandur-Mnaymneh; J Cassady; M A Hajianpour; J Paz; E Reiss
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

10.  Clonality of the parathyroid nodules with uremic parathyroid hyperplasia.

Authors:  L Shan; K Kakudo; M Nakamura; Y Nakamura; T Yokoi; J Ishimoto; K Kawahara; H Takami
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.